These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7506868)

  • 21. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies on Suncefal (cefpiramide) concentration in prostatic tissue and bladder wall].
    Okishio N; Yonezu M; Hanai S; Ishiguro K; Yanaoka M; Naide Y
    Hinyokika Kiyo; 1988 Mar; 34(3):551-4. PubMed ID: 2455441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tissue concentrations of mezlocillin in prostate adenomas following intravenous bolus injections and continuous infusions].
    Naber K; Adam D
    Fortschr Med; 1983 Nov; 101(41):1862-8. PubMed ID: 6197351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostatic tissue levels of cefpiramide (CPM)].
    Takata K; Kawamura S; Yoshida I
    Hinyokika Kiyo; 1988 Jun; 34(6):1105-8. PubMed ID: 2464916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum and prostatic tissue concentration of ceftizoxime (CZX) after intravenous administration in cases of benign prostatic hypertrophy].
    Wakatsuki A; Nishio S; Morita M; Takeuchi M; Murase M
    Hinyokika Kiyo; 1985 Nov; 31(11):2080-4. PubMed ID: 2418663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gentamicin level in the prostate and its pharmacokinetics in patients with benign prostatic hypertrophy].
    Dyderski S; SokoĊ‚owski W
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):517-9. PubMed ID: 1705021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of prostatic tissue levels of cefoperazone].
    Yoshida H; Hoshino M; Haraguchi C; Ogawa Y; Kawai N; Sakurai H; Ishihara Y; Higaki Y; Imamura K
    Hinyokika Kiyo; 1985 May; 31(5):871-4. PubMed ID: 2413746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on transfer of ceftizoxime into prostatic and vesical tissues].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1984 Feb; 30(2):259-64. PubMed ID: 6204521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate.
    Goto T; Makinose S; Ohi Y; Yamauchi D; Kayajima T; Nagayama K; Hayami H
    Int J Urol; 1998 May; 5(3):243-6. PubMed ID: 9624555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tissue concentrations of sulfametrol-trimethoprim in the human prostate (author's transl)].
    Bergmann M; Lederer B; Takacs F
    Urologe A; 1979 Nov; 18(6):335-7. PubMed ID: 92090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transfer of ceftizoxime into serum and prostatic tissue].
    Fujisawa M; Mizunaga M; Arima S; Tokunaka S; Inada F; Takamura T; Yachiku S
    Hinyokika Kiyo; 1985 Oct; 31(10):1855-9. PubMed ID: 2418658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of levels of latamoxef in prostatic tissue and bladder mucosal tissue].
    Nakata Y; Mizunaga M; Morikawa M; Osanai H; Fujisawa M; Inada F; Yachiku S
    Hinyokika Kiyo; 1987 Feb; 33(2):289-93. PubMed ID: 2438917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of the prostatic tissue cefbuperazone (CBPZ) level].
    Fjuii H; Niibori D; Okamura K; Hashimoto H; Tokunaka S; Yachiku S; Osanai H
    Hinyokika Kiyo; 1988 May; 34(5):932-6. PubMed ID: 2459941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the diffusion of cephapirin into prostatic tissue].
    Adam D; Hofstetter AG; Staehler G
    Fortschr Med; 1977 Sep; 95(34):2107-9. PubMed ID: 71258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of prostatic tissue levels of cefodizime (CDZM)].
    Yamada Y; Fukatsu H; Kamijo A; Mizumoto H; Taki T; Mitsui K; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y
    Hinyokika Kiyo; 1994 Apr; 40(4):365-9. PubMed ID: 7514846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.